Active8: a randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with TLR8 agonist VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)

Ferris, Robert L and Cohen, Ezra and Gash, Kelly and Whiting, Sam and Manjarrez, Kristi and Dietsch, Greg and Hershberg, Robert and Bryan, James (2014) Active8: a randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with TLR8 agonist VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Journal for ImmunoTherapy of Cancer, 2 (Suppl ). P69 - P69. ISSN 2051-1426

Preview	PDF Published Version Available under License : See the attached license file. Download (153kB) | Preview
	Plain Text (licence) Available under License : See the attached license file. Download (1kB)

---

Share

Citation/Export:	Select format... Citation - Text Citation - HTML Endnote BibTex Dublin Core OpenURL MARC (ISO 2709) METS MODS EP3 XML Reference Manager Refer
Social Networking:	Share |

---

Details

Item Type:	Article
Status:	Published
Creators/Authors:	Creators Email Pitt Username ORCID Ferris, Robert L rlf1@pitt.edu RLF1 Cohen, Ezra Gash, Kelly Whiting, Sam Manjarrez, Kristi Dietsch, Greg Hershberg, Robert Bryan, James
Centers:	Other Centers, Institutes, Offices, or Units > Pittsburgh Cancer Institute
Date:	2014
Date Type:	Publication
Journal or Publication Title:	Journal for ImmunoTherapy of Cancer
Volume:	2
Number:	Suppl
Publisher:	BMJ
Page Range:	P69 - P69
DOI or Unique Handle:	10.1186/2051-1426-2-s3-p69
Schools and Programs:	School of Medicine > Otolaryngology
Refereed:	Yes
ISSN:	2051-1426
Date Deposited:	21 Dec 2016 20:51
Last Modified:	01 Jul 2023 11:58
URI:	http://d-scholarship.pitt.edu/id/eprint/29464

---

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com

---

Actions (login required)

View Item